Matt Seefeld is Executive Vice President at MedEvolve and Will Mowe is Executive Director of Rebound Orthopedics and Neurosurgery. Today, Rebound is achieving better bottom-line performance with fewer FTEs. Zero touch claims that require no human intervention now account for 62% of total, and a closed balance net collection rate above benchmark at 98%.
2024 Black Book Report: MedEvolve is #1 again for RCM Automation & Optimization
MedEvolve ranked #1 overall and in 12 out of 18 categories. Download the report and compare to our 2023 #1 rankings.